Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements

PURPOSE: Cardiac involvement predicts poor prognosis in light chain (AL) amyloidosis, and the current prognostic classification is based on cardiac biomarkers troponin-T (cTnT) and N-terminal pro–B-type natriuretic peptide (NT-ProBNP). However, long-term outcome is dependent on the underlying plasma...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Kumar, Shaji, Dispenzieri, Angela, Lacy, Martha Q., Hayman, Suzanne R., Buadi, Francis K., Colby, Colin, Laumann, Kristina, Zeldenrust, Steve R., Leung, Nelson, Dingli, David, Greipp, Philip R., Lust, John A., Russell, Stephen J., Kyle, Robert A., Rajkumar, S. Vincent, Gertz, Morie A.
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Clinical Oncology 2012
Assuntos:
Original Reports
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3675680/
https://ncbi.nlm.nih.gov/pubmed/22331953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.38.5724
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares